Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: SIRTs Keep Brain Minty Fresh
25 July 2010. The sirtuin protein SIRT1 is emerging as an important player in learning and memory, and may have potential as a therapeutic target in Alzheimer disease. Fresh on the heels of a July 11 Nature paper that demonstrated a crucial role for SIRT1 in memory (see ARF related news story on Gao et al., 2010), two new papers add to the growing body of evidence that SIRT1 helps keep brains healthy. In a paper appearing July 21 in the Journal of Neuroscience, researchers led by Valter Longo at the University of Southern California, Los Angeles, show that a SIRT1 knockout mouse has numerous defects in learning and memory. This finding implies that SIRT1 could have a protective role in AD, and indeed, in a July 23 Cell paper, researchers led by Leonard Guarente at the Massachusetts Institute of Technology, Cambridge, report that overexpression of SIRT1 can decrease Aβ production and the number of amyloid plaques in a mouse model of AD.

SIRT1, a NAD-dependent deacetylase, is known to regulate numerous biological processes and to affect longevity. Longo and colleagues wanted to investigate what role the enzyme might play in normal brains. First author Shaday Michán confirmed that SIRT1 is highly expressed in neurons of the hippocampus, including in CA1, CA3, and the dentate gyrus, all regions important for memory. Michán and colleagues then investigated the functional role of SIRT1 by analyzing a SIRT1 knockout mouse line. The SIRT1 KOs demonstrated poorer immediate memory, associative memory (as seen in classical conditioning paradigms), and spatial learning. Although basal synaptic transmission was normal in the KOs, long-term potentiation (LTP) was impaired. The SIRT1 KOs also showed subtle structural defects. The structure of dendritic spines in CA1 was normal, but the granule cells in the dentate gyrus had smaller dendritic arbors, with fewer and shorter branches.

The authors have previously shown that phosphorylation of extracellular signal-regulated kinase 1 (ERK1) is decreased in the SIRT1 KO mouse (see ARF related news story on Li et al., 2008), while other researchers have shown that SIRT1 KOs have decreased levels of insulin-like growth factor 1 (IGF-1) (see Lemieux et al., 2005). Michán and colleagues looked for changes in hippocampal gene expression in the SIRT1 KOs using microarrays. The changes were small, but included genes regulated by ERK1/2 and IGF-1, as well as other genes involved in synaptic function and metabolism.

The next step, Longo said, will be to search for the mechanism behind SIRT1’s effects by seeing if an increase in IGF-1, for example, can reverse the learning disabilities of the KO mice. Longo suggested that the effects seen in the KO mouse might not be reversible through a single signaling pathway such as IGF-1, however, as SIRT1 is a regulatory protein that seems to coordinate numerous metabolic pathways. “It’s not clear yet whether these defects [in the SIRT1 KO] are in fact primarily in learning and memory, or primarily in these metabolic pathways that are so important for learning and memory.”

Michán and colleagues also examined a transgenic mouse that overexpressed SIRT1 16-fold in the brain. On this normal mouse background, the authors found that this massive SIRT1 overexpression conferred no improvements in learning or memory, and that synaptic function was unchanged except for a slight increase in neuronal excitability.

The second paper, by Guarente and colleagues, describes work first reported at the Keystone Symposium held 10-15 Jan at Copper Mountain, Colorado (see ARF related news story for full report). First author Gizem Donmez crossed a mouse that had a mild twofold overexpression of SIRT1 in the brain with an AD mouse model that expressed APP and PS1 (APPSwe/PS1ΔE9), and discovered that SIRT1 can protect against AD, lowering the production of Aβ and the number of plaques. The authors also crossed the AD mouse with a mouse that had a brain-specific conditional KO of SIRT1, and saw that Aβ and plaques increased.

These scientists found that SIRT1 increases levels of ADAM10, the α-secretase responsible for alternate cleavage of APP. In part, SIRT1 does this by coactivating the retinoic acid receptor β. Activation of α-secretase also led to increased cleavage of the Notch receptor; the Notch intracellular domain is known to activate genes for neurogenesis. Guarente and colleagues suggest, therefore, that SIRT1 may protect against AD by decreasing Aβ production and by increasing neurogenesis.

“SIRT1 does seem to be broadly protective in neurodegeneration,” David Sinclair of Harvard Medical School, a coauthor on the J Neurosci paper, wrote in an e-mail to ARF, “so brain-penetrant activators of SIRT1 could be a potential way to prevent and possibly treat AD.”—Madolyn Bowman Rogers.

References:
Michán S, Li Y, Chou MM, Parrella E, Ge H, Long JM, Allard JS, Lewis K, Miller M, Xu W, Mervis RF, Chen J, Guerin KI, Smith LE, McBurney MW, Sinclair DA, Baudry M, de Cabo R, Longo VD. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 2010 Jul 21;30(29):9695-9707. Abstract

Donmez G, Wang D, Cohen DE, Guarente L. SIRT1 suppresses beta-amyloid production by activating the alphα-secretase gene ADAM10. Cell 2010 Jul 23;142(2):320-32. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad